An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 22 Nov 2016
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV-1 infections
- Focus Expanded access; Therapeutic Use
- Sponsors ViiV Healthcare
- 08 Sep 2016 Status changed from active, no longer recruiting to completed.
- 19 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 31 Jan 2013 Planned end date changed from 23 May 2014 to 1 Jan 2020 as reported by ClinicalTrials.gov.